OWENS DAVID (Chief Medical Officer) purchased 0.7% of their position (1K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $950.00 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/15/2024ACC: 0001829126-24-005573
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1K
Net shares
Net buyer
$950.00
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1K
Price / share
$0.95
Trade value
$950.00
% of position
0.7%
8/13/2024
146.79K→147.79K
Total
Net shares
+1K
Net value
$950.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 8/13/2024 | P · Purchase | +1K | $0.95 | $950.00 | 0.7% | 146.79K | 147.79K |
| Total | +1K | $950.00 | ||||||
Derivative Transactions0
No derivative transactions reported